Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2017

Streicher Samantha A, Klein Alison P, Olson Sara H, Amundadottir Laufey T, DeWan Andrew T, Zhao Hongyu, Risch Harvey A

Abstract excerpt

Background: The higher risk of pancreatic cancer in Ashkenazi Jews compared with non-Jews is only partially explained by the increased frequency of BRCA1 and BRCA2 mutations in Ashkenazi Jews.Methods: We evaluated the impact of 16 established pancreatic cancer susceptibility loci in a case-control sample of American Jews, largely Ashkenazi, including 406 full-Jewish pancreatic cancer patients and 2,332...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 gene
Share to BRCA2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Loci

Share to Genetic Predisposition to Disease

Share to Pancreatic Neoplasms

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 28754795
DOI: 10.1158/1055-9965.EPI-17-0262
PMCID: PMC5626623

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews.PMID 28754795Read ↗

A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population.Semantic proximity Read ↗

Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.Semantic proximity Read ↗

BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.Semantic proximity Read ↗

Differential analysis of mutations in the Jewish population and their implications for diseases.Semantic proximity Read ↗

Familial pancreatic carcinoma in Jews.Semantic proximity Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

Identifying Ashkenazi Jewish <i>BRCA1/2</i> founder variants in individuals who do not self-report Jewish ancestrySemantic proximity Read ↗

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.Semantic proximity Read ↗

High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic LesionsSemantic proximity Read ↗

Cancer in Jews: introduction and overview.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.